The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Open accessAbstract
Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death. However, under pathological conditions, upregulation of death receptor family ligands, such as tumour necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease. In this Review, we outline the evidence implicating necroptosis in these neurological diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation. Necroptosis is a form of cell death mediated by receptor-interacting protein kinase 1 (RIPK1), and is observed in several CNS disorders. Here, Yuan, Amin and Ofengeim give an overview of necroptosis in the CNS and explain its relationship with inflammation in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased activation of TNF/TNFR1 signalling following chronic activation of microglia can give rise to TNF-mediated necroptotic neuronal cell death, 160 which represents a possible therapeutic target in Parkinson's disease.161”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Yet, several genes that have been implicated in neuroinflammation38 (such as RIPK1) were seen specifically in microglial states associated with COVID-19.”
From Dysregulation of brain and choroid plexus cell types in severe COVID-19 (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Self-citationInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Ji, Y. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,497
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citation
Cited by
Sorted by citations
Items 801–900 of 993
Cai, L., Dou, X., Dong, W., Zou, K., Zhang, L., Hong, H., Zhang, X., Liu, J., Tian, D., Wu, X., et al. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s502775 · Cited by 1
Fumonisin B1 induces oxidative stress, inflammation and necroptosis in IPEC-J2 cells
Zou, Y., Du, X., Zheng, X., Mao, S., Xu, X., Zhang, S., & Chen, X. (2025) · Veterinary Research Communications · doi:10.1007/s11259-025-10728-6 · Cited by 1
Jin, B., Ding, Z., Sun, Y., Gao, S., Sui, X., Ding, M. Z., Qu, X., & Zheng, L. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1027 · Cited by 1
How Repair-or-Dispose Decisions Under Stress Can Initiate Disease Progression
Nold, A., Batulin, D., Birkner, K., Bittner, S., & Tchumatchenko, T. (2020) · iScience · doi:10.1016/j.isci.2020.101701 · Cited by 1
Neсroptosis and the experience of its targeted modulation in the context of personalized medicine
Dmitriev, Y. V., & Galagudza, M. M. (2022) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2022-2-2-33-45 · Cited by 1
Xiang, Z., Mranda, G. M., Zhou, X., Xue, Y., Wang, Y., Tian, W., Liu, J., & Ding, Y. (2022) · Medicine · doi:10.1097/md.0000000000030219 · Cited by 1
Hachenberg, T., Meyer, J., Sielenkämper, A. W., Kraft, W., Vogt, B., Breithardt, G., & Lawin, P. (1993) · PubMed · Cited by 1
Silva‐Islas, C. A., Santana-Martínez, R. A., León‐Contreras, J. C., Barrera‐Oviedo, D., Pedraza‐Chaverrí, J., Hernández‐Pando, R., & Maldonado, P. D. (2022) · Research Square · doi:10.21203/rs.3.rs-1443129/v1 · Cited by 1
Liu, Y., Dong, Y., Liu, Z., Wang, Y., Chai, Y., Han, Z., Wei, W., & Chen, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2158508/v1 · Cited by 1
Wang, D., Wu, S., & Zhu, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4704421 · Cited by 1
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.04.556212 · Cited by 1
Role of RIPK1 in Diffuse Gliomas pathologyPreprint
Morales, L. C. A., Bergna, S. M. G., Marchesini, A., Scalise, M. L., González, N., Candolfi, M., Romanowski, V., & Pidre, M. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.11.566709 · Cited by 1
Ren, X., Huo, J., Li, X., Wang, M., Jin, P., Nie, N., Zhang, J., Huang, J., Zheng, Y., & Ge, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4368339/v1 · Cited by 1
Mohammed, S., Nicklas, E. H., Thadathil, N., Selvarani, R., Royce, G. H., Richardson, A. G., & Deepa, S. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.17.254888
Maramukha, V. (2020) · Technology transfer innovative solutions in medicine · doi:10.21303/2585-663.2020.001491
IRF1-triggered ZBP1 Transcription Mediates Cell Death of NeuronsPreprint
Zhou, H., Liu, J., Lu, Y., Chen, Y., Limpanon, Y., Dekumyoy, P., Wei, H., Maleewong, W., & Lv, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-487257/v1
Wang, Y., Niu, Y., Lin, F., Su, P., Chen, L., Liu, D., & Sun, Y. A. (2021) · Research Square · doi:10.21203/rs.3.rs-981068/v1
Yang, X., Lu, H., Xie, H., Zhang, B., Nie, T., Fan, C., Yang, T., Xu, Y., Su, H., Tang, W., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202114922
Bigio, M. R. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316671863.030
Zhou, X., Zhu, Y., Gao, L., Li, Y., Li, H., Liu, Y., Hu, A., Ying, C., & Song, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2006841/v1
Chen, J., Tao, Q., Lang, Z., Jin, Y., Chen, G., Li, X., Yu, Z., & Li, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.967613
Yao, J., Dai, X., Yu, X., Teng, W., Yu, W., Kuang, B., Li, M., Liu, X., Zheng, L., Cao, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1990560/v1
States of Ill Health: The Ground of Clinical Presentations
Smith, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-13388-6_7
Zhao, B., Gui, L., Zhang, Z., Xiang, Y., Sun, X., Fan, J., & Huang, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2488288/v1
The early prognostic value of the 1-4-day BCM/PA trend after admission in neurocritical patientsPreprint
Li, F., Peng, J., Xiang, Y., Liu, G., & Ling, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2574877/v1
Research Progress of RIPK1 and Amyotrophic Lateral Sclerosis
袁, 如. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133610
Chen, Y., Zhang, H., Jiang, L., Cai, W., Kuang, J., Geng, Y., Xu, H., Li, Y., Yang, L., Cai, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2886437/v1
Ray, S. D., Yang, N., Niha, A., & Genis, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.01041-1
Resveratrol as a potential therapeutic molecule against neuropathy: A new narrative
Ahmad, I., Rajagopalan, R., Dey, A., & Hoda, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00049-4
Muresanu, D. F., Sharma, A., Tian, Z. R., Lafuente, J. V., Nozari, A., Feng, L., Buzoianu, A. D., Wiklund, L., & Sharma, H. S. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_6
Role of microglia in the pathogenesis of multiple sclerosis and links to immunomodulatory therapy
Valiukevičius, P., Liutkevičienė, R., & Balnytė, R. (2023) · Neurologijos seminarai · doi:10.29014/ns.2022.26.14
Targeting Various Pathogenic Pathways for the Development of Anti-alzheimer’s Drugs: An Update
Ambreen, S., Fatima, N., Umar, M., Shaququzzaman, M., Alam, M. M., & Ali, R. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266274924231002110733
Zhu, Z., Zhou, L., Wang, Y., Zhang, X., Zhang, D., Li, X., Zhao, B., & Jia, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.23.573195
Inhibition of necroptosis mitigates paclitaxel-induced neuronal damage and cognitive impairmentPreprint
Liu, L., Zhao, S., Zhao, L., Li, H.-Z., Liu, X., & Wang, X.-L. (2024) · Research Square · doi:10.21203/rs.3.rs-3841052/v1
Wang, L., Song, J., Xu, J., Qin, Y., Li, J., Sun, Y., Jin, H., Chen, J., & Wang, Z. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.29.582704
Chen, L., Bai, J., Yang, X., Deng, Y., Song, Y., Xiang, G., Duan, R., & Zheng, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4784292
Zhang, J., Xie, S., Xiao, R., Yang, D., Zhi, Z., & Li, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22697040
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2023) · Figshare · doi:10.6084/m9.figshare.24630289
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25001647
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495854
Advancements in the Research of Cell Death in Tumors
赖, 鑫. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1471987
Harnessing dual-mode RIPK1 ligands for cross-species anti-necroptosis inhibitor compounds
Petró, J. L., Bana, P., Linke, N., Szabó, J. E., Szalai, K. K., Kálomista, I., Vass, C., Hornyánszky, G., Greiner, I., & Éles, J. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129970
Hierarchical Genomic Analysis of Susceptibility to Schizophrenia in Sudanese multi-case families
Saeed, A., Ahmed, L., Abuswar, S., Salih, M., Hussein, A. A., Eltigani, A., Elgizouli, M., & Ibrahim, M. E. (2024) · F1000Research · doi:10.12688/f1000research.154747.1
Sirolimus as a possible treatment in cleavage-resistant RIPK1-induced autoinflammatory syndrome
Cattalini, M., Cortesi, M., Baronio, M., Insalaco, A., Benedetti, F. D., Lougaris, V., & Badolato, R. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.11.003
Design and synthesis of pyridazin‐4‐one derivatives as necroptosis inhibitors
An, Y., Peng, X., Wang, T., Liu, K., Feng, D., Chen, F., Zhou, X., Geng, M., Duan, W., Ai, J., et al. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400594
Li, M., Shi, Y.-L., He, X., Wang, S.-C., Liu, J., Wang, Z., Dang, H., & Yu, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5073206
Shang, H., Shi, J., Zhu, J., Guo, Y., & Wang, X. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26186
TNF-α mediates activation of neuronal necroptotic signaling in rat with syringomyelia
Li, J., Cui, S., Li, Y., Bai, J., Zhang, C. M., Li, K., & Jian, F. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115214
Withdrawal notice to: ATR-mediated phosphorylation of RIPK1 inhibits DNA damage-induced necroptosis
Shi, S.-N., Xu, Q., Jiao, X., Wen, Y., Wu, Y., Liu, J., Ma, D., Zhao, B., Gao, Q., & Fang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116949
RetractedNecroptosis, Autophagy and Parthanatos in the Pathogenesis of Brain Diseases
Golushko, N. I., Martynov, D. D., Lebedev, A. S., Ilyin, N. P., Galstyan, D. S., & Kalueff, A. V. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025020085
Investigating the role of necroptosis in the immunological microenvironment of periodontitis
Chen, Y., Wang, T., Zheng, Z., Ai, Z., Jiang, J., & Li, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10589-x
Ren, X., Huo, J., Li, X., Min, W., Jin, P., Neng, N., Jing, Z., Zheng, Y., Huang, J., & Ge, M. (2025) · Advanced Biology · doi:10.1002/adbi.202400577 · Cited by 1
Structural and temporal dynamics analysis on PANoptosis in sepsis: a bibliometric analysisPreprint
Li, Z., Nie, D., Yin, L., Qin, Q., Yang, C., Li, R., Gao, X., Yu, X., & Wang, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.02.657552
Autophagy and Apoptosis Following Subarachnoid Hemorrhage
孙, 景. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1561763
Shade, L. M. P., Sharifitabar, M., Beiser, A., Satizábal, C. L., Mosley, T. H., Curran, J. E., Bressler, J., Heckbert, S. R., Hughes, T. M., Austin, T. R., et al. (2025) · medRxiv · doi:10.1101/2025.06.11.25329426
Jiang, F., Sun, Y., Wu, W. E., & Li, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6543877/v1
Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1
Soday, L., Seripracharat, C., Gray, J. L., Luz, A. F. S., Howard, R. T., Singh, R., Burden, T. J., Bernardini, E., Mateus‐Pinheiro, M., Petersen, J. F. W., et al. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00112
Liu, H., Wang, H., Zheng, H., & Chen, X. (2025) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2025.100012
Khandia, R., Gurjar, P., Khan, A. A., Gaur, T., & Fatima, S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149825
Role and relation of cell death in Alzheimer’s disease
Hoang, D. A., Le, D. A., Do, T. M. H., & Than, V. T. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.024
Regulated cell death: Discovery, features, and implications for neurodegenerative diseases
Pandey, S. K., Nanda, A., Singh, S., & Singh, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00001-2
Necroptosis in neurodegenerative disorders
Roy, T., Chatterjee, A., & Swarnakar, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00014-0 · Cited by 1
Wang, T., Ding, F., & Sun, K. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1527907
A patent review of MLKL modulators (2023 – present)
Wan, B., Jiang, C., & Zhuang, C. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2563877
Du, M.-C., Kang, Y., Hu, Y., Long, X., Jiang, J.-J., & Gong, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7250504/v1
Wang, Y., Ye, J., Huang, J., Ye, H., Zhang, Z., Cai, Y., & Su, C. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s556157
Sun, K., Wang, K.-R., Wen, S., Hong, J.-J., Fei, Y., Pan, Q.-H., & Xie, F. (2025) · PeerJ · doi:10.7717/peerj.20260
Stress Granules: Novel Regulators of Programmed Cell Death
Xu, J., Yan, L., Li, X., Hu, K. R., Tang, S., Wang, G., Guo, Y., & Liu, P. (2025) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575415756251008112135
Liu, R., Wei, J., Luo, Z., Gao, X., Zhang, H., & Kong, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1658769
Otmakhov, A., Bakirov, L. R., Незнанов, Н. Г., & Asadullin, A. R. (2025) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2025-4-2-1099
Back, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00810
Gasdermin E couples mitochondrial damage to pyroptotic neurodegeneration in Parkinson’s diseasePreprint
Pan, J., Geng, L., Liu, X., Wang, Y., Fang, N., Xie, F., Shen, Y., Deng, Y., Han, Y., Li, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.14.694264
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495836
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909791
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495851
Jayaraman, A., Htike, T. T., James, R., Picón, C., & Reynolds, R. (2021) · Figshare · doi:10.6084/m9.figshare.16778490
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667879
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667882
Geng, L., Gao, W., Saiyin, H., Li, Y., Zeng, Y., Zhang, Z., Li, X., Liu, Z., Gao, Q., An, P., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24715471
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736747
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667885
Luo, H., Liu, N., & Lin, C. (2024) · Figshare · doi:10.6084/m9.figshare.25248899
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2024) · Figshare · doi:10.6084/m9.figshare.24630466
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495842
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736717
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736732
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909785
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909782
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736726
Park, H.-H., Kim, H.-R., Park, S.-Y., Hwang, S.-M., Hong, S. M., Park, S., Kang, H. C., Morgan, M. J., Cha, J.-H., Lee, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16305850
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25001743
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495833
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644468
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736729
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736735
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909776
Zhang, K., Li, J., & 袁恩武 (2023) · Figshare · doi:10.6084/m9.figshare.23689724
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909779
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736723
Metadata
- Authors
- Yuan, J., Amin, P., & Ofengeim, D.
- Affiliations
- Harvard University (US)
- Sanofi (United States) (US)
- Corresponding author
- Yuan, Junying
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-11-22
- Volume
- 20
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC6342007
- OpenAlex
- W2901410206
- Semantic Scholar
- a6626d511f6ce29e1ffd0f9740b5c693cadb4fb3
- Cited by
- 967
- References
- 179
- Citations by year
- 2026: 110 · 2025: 156 · 2024: 149 · 2023: 152 · 2022: 164 · 2021: 134 · 2020: 65 · 2019: 35
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Denali Therapeutics
- National Institutes of Health (4r01ns082257-04)
- National Institute on Aging (RF1AG055521, R01AG047231, R21AG059073)
- National Institute of Neurological Disorders and Stroke (R01-NS082257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- necroptosis, RIPK1, neuroinflammation, RIPK3, MLKL, apoptosis, TNF-α, death receptor ligands, neurodegenerative diseases, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, central nervous system disorders
- MeSH terms
- Necroptosis, Animals, Brain, Humans, Inflammation, Neurons, Phosphorylation, Neurodegenerative Diseases, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review